INVO Fertility, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
INVO Fertility, Inc. (IVF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $31.29 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-08-14
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-06-30 was $0.00.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-03-31 was $31.29K, a 85.06% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-12-31 was -$13.62K, a 119.73% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-09-30 was -$155.66K, a 325.48% decline year-over-year.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $278.41K, a 73.46% decline from fiscal 2023.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $1.05M, a 35.10% decline from fiscal 2022.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $1.62M, a 4.70% increase from fiscal 2021.
- INVO Fertility, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2021 was $1.54M, a 3.22% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $31.29K 10-Q · filed 2026-08-14 | $17.66K derived: sum of 3 quarters · filed 2026-08-14 | -$138.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $31.29K 10-Q · filed 2026-06-22 | $17.66K derived: sum of 2 quarters · filed 2026-08-14 | -$138.00K derived: sum of 3 quarters · filed 2026-08-14 | -$138.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$13.62K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-14 | -$169.28K derived: sum of 2 quarters · filed 2026-08-14 | -$169.28K derived: sum of 3 quarters · filed 2026-08-14 | $40.09K 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$155.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$155.66K derived: sum of 2 quarters · filed 2025-11-17 | $53.71K 10-Q · filed 2025-11-17 | $122.75K derived: sum of 4 quarters · filed 2026-06-02 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $209.37K 10-Q · filed 2025-08-14 | $278.41K derived: sum of 3 quarters · filed 2026-06-02 | $347.44K derived: sum of 4 quarters · filed 2026-06-02 |
| 2025-03-31 | $209.37K 10-Q · filed 2025-05-20 | $278.41K derived: sum of 2 quarters · filed 2026-06-02 | $347.44K derived: sum of 3 quarters · filed 2026-06-02 | $416.48K derived: sum of 4 quarters · filed 2026-06-02 |
| 2024-12-31 | $69.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $138.07K derived: sum of 2 quarters · filed 2026-06-02 | $207.10K derived: sum of 3 quarters · filed 2026-06-02 | $278.41K 10-K · filed 2026-06-02 |
| 2024-09-30 | $69.03K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-19 | $138.07K derived: sum of 2 quarters · filed 2024-11-19 | $209.37K 10-Q · filed 2024-11-19 | $362.22K derived: sum of 4 quarters · filed 2025-04-30 |
| 2024-06-30 | $69.03K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-11-19 | $140.34K 10-Q/A · filed 2024-11-19 | $293.19K derived: sum of 3 quarters · filed 2025-04-30 | $534.52K derived: sum of 4 quarters · filed 2025-04-30 |
| 2024-03-31 | $71.30K 10-Q · filed 2024-05-15 | $224.15K derived: sum of 2 quarters · filed 2025-04-30 | $465.49K derived: sum of 3 quarters · filed 2025-04-30 | $525.44K derived: sum of 4 quarters · filed 2025-04-30 |
| 2023-12-31 | $152.85K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | $394.18K derived: sum of 2 quarters · filed 2025-04-30 | $454.14K derived: sum of 3 quarters · filed 2025-04-30 | $1.05M 10-K · filed 2025-04-30 |
| 2023-09-30 | $241.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $301.29K derived: sum of 2 quarters · filed 2023-11-13 | $896.26K 10-Q · filed 2023-11-13 | $1.65M derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-06-30 | $59.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $654.92K 10-Q · filed 2023-08-14 | $1.41M derived: sum of 3 quarters · filed 2024-11-19 | $1.41M derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-03-31 | $594.97K 10-Q · filed 2023-05-15 | $1.35M derived: sum of 2 quarters · filed 2024-11-19 | $1.35M derived: sum of 3 quarters · filed 2024-11-19 | $1.78M derived: sum of 4 quarters · filed 2024-11-19 |
| 2022-12-31 | $755.12K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | $755.12K derived: sum of 2 quarters · filed 2024-11-19 | $1.19M derived: sum of 3 quarters · filed 2024-11-19 | $1.62M 10-K/A · filed 2024-11-19 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $432.80K derived: sum of 2 quarters · filed 2022-11-14 | $861.28K 10-Q · filed 2022-11-14 | $1.27M derived: sum of 4 quarters · filed 2023-04-17 |
| 2022-06-30 | $432.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $861.28K 10-Q · filed 2022-08-15 | $1.27M derived: sum of 3 quarters · filed 2023-04-17 | $1.64M derived: sum of 4 quarters · filed 2023-04-17 |
| 2022-03-31 | $428.49K 10-Q · filed 2022-05-16 | $835.27K derived: sum of 2 quarters · filed 2023-04-17 | $1.21M derived: sum of 3 quarters · filed 2023-04-17 | $1.60M derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-12-31 | $406.78K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $783.31K derived: sum of 2 quarters · filed 2023-04-17 | $1.17M derived: sum of 3 quarters · filed 2023-04-17 | $1.54M 10-K · filed 2023-04-17 |
| 2021-09-30 | $376.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $760.61K derived: sum of 2 quarters · filed 2021-11-15 | $1.14M 10-Q · filed 2021-11-15 | $1.72M derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-06-30 | $384.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $760.61K 10-Q · filed 2021-08-16 | $1.35M derived: sum of 3 quarters · filed 2022-03-31 | $1.66M derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-03-31 | $376.52K 10-Q · filed 2021-05-17 | $961.82K derived: sum of 2 quarters · filed 2022-03-31 | $1.28M derived: sum of 3 quarters · filed 2022-03-31 | $1.49M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-12-31 | $585.30K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $899.35K derived: sum of 2 quarters · filed 2022-03-31 | $1.12M derived: sum of 3 quarters · filed 2022-03-31 | $1.50M 10-K · filed 2022-03-31 |
| 2020-09-30 | $314.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $531.91K derived: sum of 2 quarters · filed 2020-11-16 | $910.44K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $217.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $596.39K 10-Q · filed 2020-08-13 | ||
| 2020-03-31 | $378.54K 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | $69.79K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |